Gene · 1830
Papers2,614
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,614
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pathogenic relevance of antibodies against desmoglein 3 in patients with oral lichen planus. | J Dtsch Dermatol Ges | 2024 | 39152677 | PubTator, text mining | PubMed |
| Case report: Managing pemphigus foliaceus using apremilast without systemic glucocorticosteroids or immunosuppressive agents. | Front Immunol | 2024 | 39139566 | PubTator, text mining | PubMed |
| The desmosome comes into focus. | J Cell Biol | 2024 | 39120608 | PubTator, text mining | PubMed |
Co-occurrence of oral pemphigus vulgaris and herpes simplex virus infection in a young patient with Crohn's disease: report of a rare case of oral lesions during anti-TFN alpha and immunomodulator therapy. | Int J Colorectal Dis | 2024 | 39105861 | PubTator, text mining | PubMed |
| A 3-year-old child with multiple superficial erosions and yellowish crusts on the scalp and seborrheic areas. | JAAD Case Rep | 2024 | 39100801 | PubTator, text mining | PubMed |
| Alteration of reactive oxygen species master transcription factor Nrf2 in keratinocytes exposed to monoclonal pathogenic antibody AK23 against desmoglein-3 in pemphigus vulgaris. | Autoimmunity | 2024 | 39037929 | PubTator, text mining | PubMed |
| Activity of apremilast in a patient with severe pemphigus vulgaris: case report. | Front Immunol | 2024 | 38983857 | PubTator, text mining | PubMed |
| Multiplex Intraoperative Rapid Immunohistochemistry with Noncontact Antibody Mixing for Distinguishing the Histologic Phenotype of Lung Cancer. | Pathobiology | 2024 | 38934168 | PubTator, text mining | PubMed |
| State-of-the-art diagnosis of autoimmune blistering diseases. | Front Immunol | 2024 | 38903493 | PubTator, text mining | PubMed |
| Mutant TP53 promotes invasion of lung cancer cells by regulating desmoglein 3. | J Cancer Res Clin Oncol | 2024 | 38900156 | PubTator, text mining | PubMed |
| Factors associated with non-pathogenic antibodies against desmoglein-3 in pemphigus foliaceus. | An Bras Dermatol | 2024 | 38851894 | PubTator, text mining | PubMed |
| The emergence of circulating activated autoreactive desmoglein 3-specific follicular regulatory T cells is associated with long-term efficacy of rituximab in patients with pemphigus vulgaris. | Br J Dermatol | 2024 | 38848544 | PubTator, text mining | PubMed |
| Absence of Epidermal Antibodies in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Patients but Beware of Single Positive Results. | Dermatol Res Pract | 2024 | 38803350 | PubTator, text mining | PubMed |
| A case of bullous pemphigoid complicated by mucosal lesions due to mucosal-dominant pemphigus vulgaris: analyzing the pathogenicity of anti-desmoglein 3 antibodies using a bead aggregation assay. | Int J Dermatol | 2024 | 38741281 | PubTator, text mining | PubMed |
| The evolution of Pemphigus publications: A bibliometric analysis with research trends and global productivity. | Medicine (Baltimore) | 2024 | 38701303 | PubTator, text mining | PubMed |
| Desmosomal Hyper-Adhesion Affects Direct Inhibition of Desmoglein Interactions in Pemphigus. | J Invest Dermatol | 2024 | 38677661 | PubTator, text mining | PubMed |
| EGFR Inhibition by Erlotinib Rescues Desmosome Ultrastructure and Keratin Anchorage and Protects against Pemphigus Vulgaris IgG-Induced Acantholysis in Human Epidermis. | J Invest Dermatol | 2024 | 38642796 | PubTator, text mining | PubMed |
| Six-Gene Signature for Differential Diagnosis and Therapeutic Decisions in Non-Small-Cell Lung Cancer-A Validation Study. | Int J Mol Sci | 2024 | 38612418 | PubTator, text mining | PubMed |
| A case of IgA pemphigus with acantholysis in oral mucosal lesions. | Skin Health Dis | 2024 | 38577061 | PubTator, text mining | PubMed |
| Beyond the skin: B cells in pemphigus vulgaris, tolerance and treatment. | Br J Dermatol | 2024 | 38504438 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1830/papers?page=8